The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: UWCCC Molecular Tumor Board Registry
Official Title: UWCCC Precision Medicine Molecular Tumor Board Registry
Study ID: NCT03023202
Brief Summary: This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
Name: Mark Burkard, MD, PhD
Affiliation: University of Wisconsin, Madison
Role: PRINCIPAL_INVESTIGATOR